Helius Medical Technologies Inc (HMT) is a medical device company. It provides neurological wellness solutions. The company development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides the development of technologies as a potential treatment for neurological symptoms caused by disease or trauma. HMT provides a portable neuromodulation stimulator (PoNS) device, an investigational device in development, that enables physicians and patients to manage a host of neurological symptoms. The company offers devices that use results from the planned pivotal, multi-center mTBI study to support an application to the FDA for commercial distribution. HMT is headquartered in Newtown, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Helius Medical Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Helius Medical Technologies Inc Company Overview
- Helius Medical Technologies Inc Company Snapshot
- Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Helius Medical Technologies Inc - Pipeline Analysis Overview
- Helius Medical Technologies Inc - Key Facts
- Helius Medical Technologies Inc - Major Products and Services
- Helius Medical Technologies Inc Pipeline Products by Development Stage
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
- Helius Medical Technologies Inc Pipeline Products Overview
- PoNS Device - Cerebral Palsy
- PoNS Device - Cerebral Palsy Product Overview
- PoNS Device - Chronic Balance Disorder
- PoNS Device - Chronic Balance Disorder Product Overview
- PoNS Device - Chronic Balance Disorder Clinical Trial
- PoNS Device - Depression
- PoNS Device - Depression Product Overview
- PoNS Device - Facial Nerve Palsy
- PoNS Device - Facial Nerve Palsy Product Overview
- PoNS Device - Parkinson’s Disease
- PoNS Device - Parkinson’s Disease Product Overview
- PoNS Device - PTSD
- PoNS Device - PTSD Product Overview
- PoNS Device - Stroke
- PoNS Device - Stroke Product Overview
- PoNS Device - Stroke Clinical Trial
- Helius Medical Technologies Inc - Key Competitors
- Helius Medical Technologies Inc - Key Employees
- Helius Medical Technologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Helius Medical Technologies Inc, Recent Developments
- Sep 13, 2023: Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
- Aug 02, 2023: Helius Medical Technologies to Release Second Quarter 2023 Financial Results on August 10, 2023
- Mar 09, 2023: Helius Medical Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
- Mar 06, 2023: Helius Medical Technologies to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
- Nov 14, 2022: Helius Medical Technologies Reports Third Quarter 2022 Financial Results
- Nov 09, 2022: Helius Medical Technologies, announces participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program
- Sep 29, 2022: Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities Conference
- Aug 15, 2022: Helius Medical Technologies Reports Second Quarter 2022 Financial Results
- May 12, 2022: Helius Medical Technologies Reports First Quarter 2022 Financial Results and Provides Update on U.S. Commercial Launch of PoNS®
- Mar 14, 2022: Helius Medical Technologies Reports Fourth Quarter and Full Year 2021 Financial Results
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Helius Medical Technologies Inc Pipeline Products by Equipment Type
- Helius Medical Technologies Inc Pipeline Products by Indication
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
- Helius Medical Technologies Inc, Key Facts
- Helius Medical Technologies Inc, Major Products and Services
- Helius Medical Technologies Inc Number of Pipeline Products by Development Stage
- Helius Medical Technologies Inc Pipeline Products Summary by Development Stage
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
- Helius Medical Technologies Inc Ongoing Clinical Trials Summary
- PoNS Device - Cerebral Palsy - Product Status
- PoNS Device - Cerebral Palsy - Product Description
- PoNS Device - Chronic Balance Disorder - Product Status
- PoNS Device - Chronic Balance Disorder - Product Description
- PoNS Device - Chronic Balance Disorder - A Comprehensive Study of Investigational PoNS Therapy in Healthy Adults
- PoNS Device - Depression - Product Status
- PoNS Device - Depression - Product Description
- PoNS Device - Facial Nerve Palsy - Product Status
- PoNS Device - Facial Nerve Palsy - Product Description
- PoNS Device - Parkinson’s Disease - Product Status
- PoNS Device - Parkinson’s Disease - Product Description
- PoNS Device - PTSD - Product Status
- PoNS Device - PTSD - Product Description
- PoNS Device - Stroke - Product Status
- PoNS Device - Stroke - Product Description
- PoNS Device - Stroke - Cranial-nerve Non-invasive Neuromodulation and Dynamic Balance in Chronic Stroke Survivors
- Helius Medical Technologies Inc, Key Employees
- Helius Medical Technologies Inc, Subsidiaries
- Glossary
- Helius Medical Technologies Inc Pipeline Products by Equipment Type
- Helius Medical Technologies Inc Pipeline Products by Development Stage
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cytta Corp
- Osprey Medical Inc
- Candela Medical Inc
- D&K Healthcare Resources, Inc.
- Airxpanders, Inc.
